Physician profile
Nathan E Goldberg
NPI 1235491861
$2,623.96
in general payments reported to CMS, 2019-2025
21 companies · $537 in 2025
The $537 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $79.91 · 2021: $564 · 2022: $364 · 2023: $433 · 2024: $370 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $386.61 | 2022-2025 | Miebo, Infuse, Xiidra |
| Allergan, INC. | $330.15 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $303.25 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $297.30 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $250.20 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $200.24 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $185.11 | 2021 | |
| Lkc Technologies, INC. | $107.50 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $87.69 | 2021-2024 | Tecnis Simplicity |
| Coopervision INC. | $82.36 | 2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $66.57 | 2019-2021 | |
| Harrow Eye, LLC | $52.08 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $51.62 | 2022 | |
| Shire North American Group INC | $41.71 | 2019 | |
| Akorn Operating Company LLC | $38.77 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $36.76 | 2023-2025 | Tryptyr, Hydrus Microstent |
| Dompe US, INC. | $24.24 | 2025 | Oxervate |
| Tearlab Corp | $22.89 | 2024 | Scoutpro Osmolarity System |
| Kala Pharmaceuticals, INC. | $22.59 | 2021 | |
| Rxsight INC | $19.30 | 2022 | |
| Thea Pharma INC. | $17.02 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.